Evidence map›Paper›PMID 39414943›Full record

ArticleCommunications biology2024

snPATHO-seq, a versatile FFPE single-nucleus RNA sequencing method to unlock pathology archives.

Taopeng Wang, Michael J Roach, Kate Harvey, Javier Escudero Morlanes, Beata Kiedik, Ghamdan Al-Eryani, Alissa Greenwald, Nikolaos Kalavros, Felipe Segato Dezem, Yuling Ma and 28 more

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Integration of Bulk and Single-Cell RNA Sequencing Analyses in Biomedicine.International journal of molecular sciences · 2026
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Dissecting Normal and Abnormal Human Kidney Development Using Multiomics.Journal of the American Society of Nephrology : JASN · 2026
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors.

Taopeng Wang *Cancer Ecosystems Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.ORCID 0000-0002-9184-609X
Michael J Roach *Adelaide Centre for Epigenetics, University of Adelaide, Adelaide, SA, Australia.ORCID 0000-0003-1488-5148
Kate HarveyCancer Ecosystems Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.ORCID 0000-0002-2155-5203
Javier Escudero MorlanesKTH Royal Institute of Technology, Science for Life Laboratory, Solna, Sweden.
Beata KiedikCancer Ecosystems Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.ORCID 0000-0001-8517-5253
Ghamdan Al-EryaniCancer Ecosystems Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Alissa GreenwaldDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0001-5428-9645
Nikolaos KalavrosDepartment of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA.ORCID 0000-0001-5503-9808
Felipe Segato DezemCenter for Spatial Omics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Yuling MaDepartment of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Yered H Pita-JuarezDepartment of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Kellie WiseAdelaide Centre for Epigenetics, University of Adelaide, Adelaide, SA, Australia.
Cyril DegletagneCRCL Core facilities, Centre de Recherche en Cancérologie de Lyon (CRCL) INSERM U1052-CNRS UMR5286, Université de Lyon, Université Claude Bernard Lyon, Centre Léon Bérard, Lyon, France.
Anna ElzFred Hutch Innovation Lab, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Azi HadadianpourFred Hutch Innovation Lab, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Jack JohannesonFred Hutch Innovation Lab, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID 0009-0002-7612-1290
Fiona PakiamFred Hutch Innovation Lab, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Heeju RyuVaccine and Infectious Disease Division, Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Evan W NewellFred Hutch Innovation Lab, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID 0000-0002-2889-243X
Laurie TononCRCL Core facilities, Centre de Recherche en Cancérologie de Lyon (CRCL) INSERM U1052-CNRS UMR5286, Université de Lyon, Université Claude Bernard Lyon, Centre Léon Bérard, Lyon, France.ORCID 0009-0005-8794-7276
Andrew Kohlway10X Genomics, Pleasanton, CA, USA.
Tingsheng Drennon10X Genomics, Pleasanton, CA, USA.ORCID 0000-0002-8106-7981
Jawad Abousoud10X Genomics, Pleasanton, CA, USA.
Ryan Stott10X Genomics, Pleasanton, CA, USA.
Paul Lund10X Genomics, Pleasanton, CA, USA.ORCID 0000-0003-0496-1434
Jens Durruthy10X Genomics, Pleasanton, CA, USA.
Andres F VallejoClinical and Experimental Sciences, Sir Henry Wellcome Laboratories, Faculty of Medicine, University of Southampton, Southampton, UK.ORCID 0000-0002-4688-0598
Wenyan LiChildren's Cancer Institute, UNSW Lowy Cancer Research Centre, Kensington, NSW, Australia.
Robert SalomonChildren's Cancer Institute, UNSW Lowy Cancer Research Centre, Kensington, NSW, Australia.ORCID 0000-0003-4504-2901
Dominik KaczorowskiCellular Genomics Platform, Garvan Institute of Medical Research, Sydney, NSW, Australia.ORCID 0000-0002-9205-1934
Joanna WarrenCellular Genomics Platform, Garvan Institute of Medical Research, Sydney, NSW, Australia.
Lisa M ButlerSouth Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, SA, Australia.ORCID 0000-0003-2698-3220
Sandra O'TooleCancer Ecosystems Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Jasmine PlummerCenter for Spatial Omics, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0001-7263-350X
Ioannis S VlachosDepartment of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA.ORCID 0000-0002-8849-808X
Joakim LundebergKTH Royal Institute of Technology, Science for Life Laboratory, Solna, Sweden.ORCID 0000-0003-4313-1601
Alexander SwarbrickCancer Ecosystems Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. a.swarbrick@garvan.org.au.ORCID 0000-0002-3051-5676
Luciano G MartelottoAdelaide Centre for Epigenetics, University of Adelaide, Adelaide, SA, Australia. luciano.martelotto@adelaide.edu.au.ORCID 0000-0002-9625-1183

Funding

VIRUS-MEDIATED MYELOSUPPRESSIONP01CA018029 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI STEPHANIE J LEE · 1985 to 2026
$128.4M
Organ Specific ProjectU54HL165440 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI HONG, YOUNG-KWON, SINGHAL, DHRUV · 2022 to 2025
$5.8M
Department of Health | National Health and Medical Research Council (NHMRC) APP2004774NCI NIH HHS P01 CA018029NHLBI NIH HHS U54 HL165440
6 · The paper itself

Abstract

Formalin-fixed paraffin-embedded (FFPE) samples are valuable but underutilized in single-cell omics research due to their low RNA quality. In this study, leveraging a recent advance in single-cell genomic technology, we introduce snPATHO-seq, a versatile method to derive high-quality single-nucleus transcriptomic data from FFPE samples. We benchmarked the performance of the snPATHO-seq workflow against existing 10x 3' and Flex assays designed for frozen or fresh samples and highlighted the consistency in snRNA-seq data produced by all workflows. The snPATHO-seq workflow also demonstrated high robustness when tested across a wide range of healthy and diseased FFPE tissue samples. When combined with FFPE spatial transcriptomic technologies such as FFPE Visium, the snPATHO-seq provides a multi-modal sampling approach for FFPE samples, allowing more comprehensive transcriptomic characterization.

Indexed as

Paraffin EmbeddingSequence Analysis, RNASingle-Cell AnalysisTissue FixationFormaldehydeGene Expression ProfilingHumansTranscriptomeWorkflowFormaldehyde

Identifiers

PMID39414943
PMCPMC11484811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.